Table 1.
In situ hibridization | Immunohistochemistry | Histopathology | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ER | PR | HER2 | TP53 | Ki67 | CK5/6 | CK8/18 | ||||||||||
Age | R | S | R | LI | R | LI | R | E | R | LI | R | LI | R | R | G | S. Tumor |
55 | + | F | + | 60 | + | 20 | - | - | - | 0 | + | 99 | - | + | III | T2 |
45 | + | F | + | 5 | - | 0 | - | - | + | 80 | + | 8 | - | + | I | T2 |
64 | + | F | + | 40 | - | 0 | - | + | - | 0 | + | 35 | - | + | I | T1 |
54 | + | F | + | 80 | + | 40 | - | + | - | 0 | + | 20 | - | + | III | T1 |
47 | + | F | + | 80 | + | 80 | + | +++ | + | 95 | + | 25 | - | + | III | T3 |
ER, estrogen receptor; PR, progesterone receptor; HER2, epidermal growth factor receptor 2; CK, cytokeratin; R, result; S, staining; F, focal;
LI, labelling index (%); E, score; G, grade; S, tumor: tumor size.